Loreto Boix
4PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Apr 27, 2024
Induction of the Inflammasome Pathway by Tyrosine Kinase Inhibitors Provides an Actionable Therapeutic Target for Hepatocellular Carcinoma.Anna Tutusaus, Marco Sanduzzi-Zamparelli, Loreto Boix
|Sep 09, 2022
miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma.Patricia de la Cruz-Ojeda, Tobias Schmid, Loreto Boix
|Jan 20, 2022
The pituitary tumour-transforming gene 1/delta-like homologue 1 pathway plays a key role in liver fibrogenesis.Meritxell Perramón, Silvia Carvajal, Vedrana Reichenbach
|Jul 06, 2021
Early diarrhoea under sorafenib as a marker to consider the early migration to second-line drugs.Álvaro Díaz-González, Víctor Sapena, Loreto Boix
Pageof 1
Frequent Collaborators
3 joint publications
María Reig
2 joint publications
Víctor Sapena
1 joint publications
Álvaro Díaz-González
1 joint publications
Ferrán Torres
1 joint publications
Marco Sanduzzi-Zamparelli
1 joint publications
Leonardo G Da Fonseca
1 joint publications
Neus LLarch
1 joint publications
Gemma Iserte
1 joint publications
Sergio Muñoz-Martínez
1 joint publications
Jordi Rimola
